Clinical trial tech company Unlearn scored $50 million in a Series B financing round led by Insight Partners. Other participants in the round include Radical Ventures, 8VC, DCVC, DCVC Bio and Mubadala ...
Unlearn.AI has moved its headquarters into larger San Francisco offices in anticipation of employee growth. The locally based artificial intelligence startup relocated last month after it signed a ...
SAN FRANCISCO--(BUSINESS WIRE)--Unlearn ®, a pioneering artificial intelligence company, today announced a groundbreaking partnership with German-based APST Research (APST), a leading platform for ALS ...
Unlearn, an AI-enabled company creating digital twins of clinical trial participants, announced a partnership to advance ALS research with biotechnology company Trace Neuroscience, which creates ...
AI-powered digital twins help interpret early signals in a small Phase 2a study of a novel therapy for Alzheimer’s Disease SAN FRANCISCO & LEUVEN, Belgium--(BUSINESS WIRE)--Unlearn®, a leader in AI ...
Season 3 of MedCity’s Pivot Podcast continues with a focus on how life sciences are being transformed. One area that has recently gone through major changes is the world of clinical trials as the ...
GRAND RAPIDS, Mich. (WOOD) — Unlearning biases and promoting anti-racism is the goal of Calvin University’s “Unlearn 365.” Monday night, a documentary screening about Juneteenth wrapped up at Calvin’s ...
Twins have long played a role in the world of medical research, specifically in the area of clinical trials, where they can help measure the effectiveness of a therapy by applying a control to one of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results